All In Biotech

Drug Trial Radar · NCT00599521

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared With Vehicle Lotion in Subjects With Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Feb 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,067 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,067

Actual

Start

Nov 2007

Primary completion

Nov 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Galderma R&DIndustry
Sponsor type
Industry
First posted
Jan 23, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether Adapalene, 0.1% is safe and effective in the treatment of Acne Vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • Adapalene lotion 0.1%Drug

    Adapalene, 0.1% will be applied topically to the face, once a day, for 12 weeks

  • Adapalene Lotion VehicleDrug

    Vehicle will be applied topically to the face, once a day, for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-Primary Endpoint: Success Rate on Investigator's Global Assessment (IGA) From Baseline to Week 12Time frame: From Baseline to Week 12
  2. Co-Primary Endpoint: Absolute Change in Total Lesion Counts From Baseline to Week 12Time frame: Baseline to 12 weeks
  3. Co-Primary Endpoint: Absolute Change in Inflammatory Lesion Count From Baseline to Week 12Time frame: Baseline to Week 12
  4. Co-Primary Endpoint: Absolute Change in NonInflammatory Lesion Counts From Baseline to Week 12Time frame: Baseline to Week 12

Locations

34 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California

    San Diego, California

  • Dermatology Specialists, Inc.

    Vista, California

  • Cherry Creek Dermatology

    Denver, Colorado

  • Advanced Dermatology and Cosmetic Surgery

    Ormond Beach, Florida

  • Dermatology Research

    Pinellas Park, Florida

  • Christie Clinic, PC

    Champaign, Illinois

  • Compliant Clinical Research

    Olathe, Kansas

  • Dermatology Specialists

    Louisville, Kentucky

  • East Coast Clinical Research, Inc.

    Haverhill, Massachusetts

  • Midwest Cutaneous Research

    Clinton Township, Michigan

  • Henry Ford Medical Center-Dept. of Dermatology

    Detroit, Michigan

  • Minnesota Clinical Study Centert

    Fridley, Minnesota

  • Skin Specialists, PC

    Omaha, Nebraska

  • Cindy Lamerson

    Reno, Nevada

  • Fran Cook-Bolden

    New York, New York

  • Dermatology Associates of Rochester

    Rochester, New York

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Wake Research Associates, LLC

    Raleigh, North Carolina

  • University Dermatology Consultants

    Cincinnati, Ohio

  • Central Sooner Research

    Norman, Oklahoma

  • Northwest Cutaneous Research Specialists

    Portland, Oregon

  • Palmetto Medical Research

    Mt. Pleasant, South Carolina

  • Dermatology Associates

    Knoxville, Tennessee

  • Dermatology Research Associates

    Nashville, Tennessee

  • Tennessee Clinical Research Center

    Nashville, Tennessee

  • J&S Studies, Inc.

    Bryan, Texas

  • The Center for Skin Research

    Houston, Texas

  • Dermatology Research Center

    Salt Lake City, Utah

  • Premier Clinical Research

    Spokane, Washington

  • Dermatology Associates

    Calgary, Alberta, Canada

  • Derm Research @ 888 Inc

    Vancouver, British Columbia, Canada

  • Ultranova Skincare

    Barrie, Ontario, Canada

  • North Bay Dermatology Centre

    North Bay, Ontario, Canada

  • Siena Medical Research

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.